Frontlight ResearchEarly access
Not yet recruitingPhase 3
The Purpose of This Study is to Evaluate the Efficacy and Safety of W2505.
Key facts
- Who runs it
- GL Pharm Tech Corporation
- Where
- South Korea1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- Phase
- Phase 3
- People taking part
- 228 people, planned
- Started
- Sept 2026
- Expected to end
- Jul 2027
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- W2505
- W2505-P1
- W2505-R
- W2505-P2
- Record updated
- 5 October 2026
Who can take part
- Age
- 19 years and older
- Sex
- Men only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Male aged 19 years or older
- Capable of completing study diaries and questionnaires independently
- Signed written informed consent
- run-in medication compliance ≥ 70%
Who cannot take part
- Erectile dysfunction caused by premature ejaculation or untreated endocrine disorders (e.g., untreated hypogonadism, hyperprolactinemia)
- Primary hypoactive sexual desire
- Other exclusions applied
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of this study is to evaluate the efficacy and safety of W2505.
The 3 groups in the trial
- ExperimentalTreatment being tested
W2505 and W2505-P2, 12 weeks.
Treatment: W2505 and W2505-P2
- Placebo ComparatorPlacebo, for comparison
W2505-P1 and W2505-P2, 12 weeks.
Treatment: W2505-P1 and W2505-P2
- Active ComparatorExisting treatment, for comparison
W2505-P1 and W2505-R, 12 weeks.
Treatment: W2505-P1 and W2505-R
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Prospective, Multi-center, Randomized, Double-blinded, Placebo-controlled, Parallel, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of W2505
- Record updated
- 5 October 2026